Terms: = Lung cancer AND SYK, P43405, 6850, ENSG00000165025 AND Prognosis
5 results:
1. Polyaniline-Based Glyco-Condensation on Au Nanoparticles Enhances Immunotherapy in lung cancer.
Su WP; Chang LC; Song WH; Yang LX; Wang LC; Chia ZC; Chin YC; Shan YS; Huang CC; Yeh CS
ACS Appl Mater Interfaces; 2022 Jun; 14(21):24144-24159. PubMed ID: 35579575
[TBL] [Abstract] [Full Text] [Related]
2. American Joint Committee on cancer Tumor Staging System Predicts the Outcome and Metastasis Pattern in Conjunctival Melanoma.
Jia S; Zhu T; Shi H; Zong C; Bao Y; Wen X; Ge S; Ruan J; Xu S; Jia R; Fan X
Ophthalmology; 2022 Jul; 129(7):771-780. PubMed ID: 35245602
[TBL] [Abstract] [Full Text] [Related]
3. TREM-2 serves as a negative immune regulator through syk pathway in an IL-10 dependent manner in lung cancer.
Yao Y; Li H; Chen J; Xu W; Yang G; Bao Z; Xia D; Lu G; Hu S; Zhou J
Oncotarget; 2016 May; 7(20):29620-34. PubMed ID: 27102437
[TBL] [Abstract] [Full Text] [Related]
4. Co-expression network analysis identifies Spleen Tyrosine Kinase (syk) as a candidate oncogenic driver in a subset of small-cell lung cancer.
Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
[TBL] [Abstract] [Full Text] [Related]
5. Expression of variant isoforms of the tyrosine kinase syk determines the prognosis of hepatocellular carcinoma.
Hong J; Yuan Y; Wang J; Liao Y; Zou R; Zhu C; Li B; Liang Y; Huang P; Wang Z; Lin W; Zeng Y; Dai JL; Chung RT
Cancer Res; 2014 Mar; 74(6):1845-56. PubMed ID: 24477596
[TBL] [Abstract] [Full Text] [Related]
